1 Functional GABA-gated chloride channels are formed when cRNA encoding the Drosophila melanogaster GABA receptor subunit RDL is injected into the cytoplasm of Xenopus oocytes. Twoelectrode voltage-clamp was used to investigate allosteric modulation of GABA-induced currents recorded from the expressed, bicuculline-insensitive, RDL homo-oligomers. 2 Flunitrazepam (0.1 gM to 100JM) had no effect on the amplitude of responses to 10 gM GABA (approximately ECO), whereas 4'chlorodiazepam (100 gM) enhanced the amplitude of submaximal responses to GABA. 3-Hydroxymethyl-i-carboline (1 JM) and ethyl-fi-carboline-3-carboxylate (both 1 and 100 JM) had no effect on currents induced by 30 JgM (approximately EC50) GABA. However 100 gM 3-hydroxymethyl-,B-carboline reduced potentiation by 4'chlorodiazepam. 3 The sodium salts of pentobarbitone (10 gM to 1 mM) and phenobarbitone (50 gM to 1 mM) dosedependently enhanced submaximal GABA responses. Neither barbiturate activated currents in the absence of GABA. 4 At 10 JM, the steroids Sa-pregnan-3a-ol-20-one and alphaxalone (5a-pregnan-3a-ol-11,20-dione), potentiated submaximal GABA responses. The stereoselectivity of steroid action seen on vertebrate GABAA receptors was observed on RDL homo-oligomers as 5a-pregnan-3f5-ol-20-one (10 JiM) was without effect. None of the three steroids tested activated currents in the absence of GABA. 5 The novel anticonvulsant, loreclezole (100 JM), potentiated the response to 10 JM GABA, but not that of saturating concentrations of GABA. 3-Hexachlorocyclohexane (0.1 JM to 30 JM) was a potent enhancer of submaximal responses to GABA of RDL. 6 The potencies of barbiturates and steroids on RDL homo-oligomers resemble those observed for several in situ insect GABA receptors, whereas those of benzodiazepine binding-site ligands are considerably reduced. The differences in the benzodiazepine pharmacology of RDL homo-oligomers and native GABA receptors, may reflect roles of other subunits in native insect receptors.
Introduction
Ionotropic y-aminobutyric acid (GABA) receptors, which are widespread in the nervous system of vertebrates and invertebrates, are believed to be oligomeric proteins, composed of five subunits arranged pseudosymetrically around a central anion-selective, ion-channel. The binding of GABA elicits bursts of channel opening. Depending upon the subunit structure of the receptors, the frequency and duration of channel opening is, in some cases, subject to allosteric modulation.
Vertebrate ionotropic GABA receptors can be divided into two classes on the basis of their sensitivity to allosteric modulation. The activity of GABAA receptors, which are antagonized by bicuculline, can be either enhanced or suppressed by a range of allosteric modulators which bind to distinct sites on the receptor (Haefely, 1992; Sieghart, 1992) . Thus, certain benzodiazepines (eg. flunitrazepam), sedative barbiturates (eg. pentobarbitone), pregnane steroids (eg. 5a-pregnan-3a-ol-20-one) , and anaesthetics enhance GABA-induced currents, whereas, inverse agonists of the integral benzodiazepine binding site(s) (eg. P-carbolines) and zinc ions reduce the agonist response of certain GABAA receptor subtypes. By contrast, ionotropic, bicuculline-insensitive GABA receptors, sometimes referred to as GABAC receptors, and expressed homo-oligomers of the p subunits which these receptors are presumed to contain, appear insensitive to all tested allosteric 1 Author for correspondence. modulators of GABAA receptors (Polenzani et al., 1991; Feigenspan et al., 1993; Qian & Dowling, 1993 Wang et al., 1994) .
Pharmacological subtypes of GABAA receptors exist, which can be mimicked by recombinant receptors of different subunit composition, and there is considerable evidence that native GABAA receptors are hetero-oligomers composed of differing combinations of a, fi, y and 5 subunits (Wisden & Seeburg, 1992) . Although some allosteric modulators (barbiturates, pregnane steroids, and convulsant ligands such as picrotoxinin) show little subunit specificity when tested on various heterologously expressed GABAA receptors, the activity of benzodiazepines and zinc is strongly dependent upon the subunit type and isoform present (Pritchett et al., 1989; Draguhn et al., 1990; Puia et al., 1990a, b; Sigel et al., 1990) .
A class of insect GABA receptors exists that is insensitive to bicuculline, but which is subject to allosteric modulation (Sattelle et al., 1990; Taylor et al., 1993) . Radioligand binding data and electrophysiological studies show that the binding sites on insect GABA receptors for benzodiazepines, steroids, barbiturates, and convulsant antagonists differ from those on vertebrate GABAA receptors  Sattelle, 1990; Sattelle et al., 1991; Rauh et al., 1993) . Such differences could be explored with the aim of locating modulator binding sites, given access to a recombinant insect GABA receptor of known composition.
Recently, a cloned Drosophila melanogaster GABA receptor subunit, RDL (ffrench-Constant et al., 1991) , has been shown to form robust, functional, presumably homo-oligomeric, Bridsh Joumal of Pharmacology (19" 117, 1229 Pharmacology (19" 117, 1237 GABA receptors in transient Lee et al., 1993; Buckingham et al., 1994) and stable (Miller et al., 1994) expression systems. The known agonist and convulsant antagonist pharmacology of these expressed, bicuculline-insensitive, homo-oligomers Shirai et al., 1995) resembles that of several in situ insect GABA receptors (Sattelle, 1990; Anthony et al., 1993) . However, the extent to which the RDL homo-oligomer resembles in situ insect GABA receptors with respect to the actions of a range of allosteric modulators is unknown. When stably expressed in a Drosophila cell line, the GABA response of RDL homo-oligomers was enhanced by the pregnane steroid, 5a-pregnan-3a-ol-20-one (Millar et al., 1994) yet, in the same study, 1-10 gM concentrations of flunitrazepam and 4'-chlorodiazepam did not affect the magnitude or duration of the maximum response to GABA. The latter results distinguish RDL homo-oligomers from native insect GABA receptors, some of which are sensitive to nanomolar concentrations of these benzodiazepines Sattelle et al., 1988) . In the present study we report the effects of compounds representative of major classes of allosteric modulators of ionotropic GABA receptors of RDL homo-oligomers expressed in Xenopus oocytes.
Note on nomenclature
In this paper, RDL refers to the subunit encoded by the cDNA described by ffrench-Constant et al. (1991) , whereas, Rdl, refers to the gene at position 66F on chromosome III of Drosophila melanogaster which encodes this subunit. Although this terminology contradicts that used in some early papers, where both gene and subunit were referred to as Rdl (e.g. ffrenchConstant et Buckingham et al., 1994) , it follows recently described conventions for nomenclature (Flybase Consortium, 1995) . Furthermore, as it appears that the Rdl gene may encode, by alternate splicing, four subunits (RDL, DRC 17-1-2, and two unnamed cDNAs; Chen et al., 1994; ffrench-Constant & Rocheleau, 1994) adoption of this convention will help clarify genes and gene products under investigation.
Methods cRNA synthesis
The cloning of the cDNA encoding the wild-type (dieldrinsensitive) form of RDL has been described elsewhere (ffrenchConstant et al., 1991) . Plasmid pNB 14.1, a gift of Dr R. T. Roush (Cornell), containing the wild-type cDNA was linearized with the restriction endonuclease NotI. m7G(5')ppp(5')G capped cRNA was synthesized with SP6 RNA-polymerase (Promega) using a standard protocol (Sambrook et al., 1989) .
Oocyte preparation and cRNA injection Stage V and VI oocytes were removed from mature Xenopus laevis and defolliculated manually after a 40 min incubation with collagenase type IA (2 mg ml-) in a calcium-free version of oocyte saline (normal saline composition (yM): NaCl 100, KCl 2, CaCl2 1.8, MgCl2 1, HEPES 5, pH 7.6). Each oocyte was injected with 40-50 ng of cRNA in < 50 nl and incubated at 17-18°C in normal saline supplemented with penicillin (100 units ml-'), steptomycin (100 Mg ml-'), gentamycin (20 Mg ml-') and 2.5 gM sodium pyruvate. Electrophysiology was performed 18-72 h after cRNA injection.
Electrophysiology
Oocytes were secured in a 90 Ml Perspex recording chamber and perfused continuously with saline (5 ml min-'). Drugs were applied in the perfusate. Compounds with low aqueous solubility were dissolved initially in dimethyl sulphoxide (4'-chlorodiazepam, loreclezole, pregnane steroids, flunitrazepam, ethyl-fi-carboline-3-carboxylate, 6S-hexachloro cyclohexane), ethanol (flunitrazepam, loreclezole) or methanol (3-hydroxymethyl-f-carboline, alphaxalone) at concentrations which ensured that final solvent concentration in the perfusate never exceeded 1% v/v. Such solvent concentrations did not affect the current required to clamp the membrane at -60 mV, nor the amplitude of currents induced by 10 gM and 30 gM GABA.
Membrane currents were monitored under two-electrode voltage-clamp using IM KCl-filled electrodes (3-10 MQ) and an Axoclamp 2A amplifier (Axon Instruments). Signals were displayed on an oscilloscope (Trio) and recorded on a chart recorder (Gould). All experiments were performed at room temperature (approximately 20°C) with the membrane voltageclamp at -60 mV.
Only oocytes which yielded stable responses to at least 3 successive control applications of GABA (2 min intervals) were used to determine the dose-dependency of putative allosteric modulators. Following recovery from the control applications, each oocyte was incubated for 30-60 s in saline containing the putative modulatory compound prior to coapplication of GABA and the modulator. The process was repeated with increasing concentrations of the test compound. Where the effects of the modulatory compounds on the GABA dose-response curve were investigated, the GABA dose-response relationship of each oocyte was determined in the absence and then in the presence of the test compound. Again, the oocyte was incubated for 30-60 s in the presence of the candidate allosteric modulator before GABA was added. Data from these experiments were normalized to the maximum response observed in each cell, with GABA alone. In all experiments the peak amplitude of each GABA response was measured, and not the amplitude of the post-desensitization plateau. Numerical data are presented as the mean + one standard error of the mean. GraphPad Prism (GraphPad Software) was used to analyse dose-response data. A four parameter logistic equation (1) 
Chemicals
Reagents for cRNA synthesis were purchased from Promega (U.K.) except for m7G(5')ppp(5')G cap analogue, which was obtained from New England Biolabs (U.K.). GABA, alphaxalone (Sa -pregnan -3a -ol -11,20-dione), 4'-chlorodiazepam (Ro5-4864), flunitrazepam, 3-hexachlorocyclohexane, phenobarbitone, pentobarbitone, Sa-pregnan-3a-ol-20-one, Sa-pregnan-3,B-ol-20-one, and collagenase type IA were obtained from Sigma (U.K.). 3-Hydroxymethyl-fl-carboline and ethyl-f-carboline-3-carboxylate and were obtained from Research Biochemicals International. Loreclezole ((Z)-1-[2-chloro-2-(2,4-dichlorophenyl) ethenyl]1,2,4-triazole) was a gift of Dr N.C.
Lan (Co-Censys Inc.).
Results

Actions of GABA
In response to GABA (3 gM to 3 mM), dose-dependent inward currents were observed in oocytes injected with the RDL cRNA, voltage-clamped at -60 mV. As in previous studies Buckingham et al., 1994) , the GABA-induced current was found to reverse near the predicted oocyte chloride reversal potential ( -20 mV), and desensitization was observed at higher concentrations of GABA (data not shown). The normalized GABA dose-response curve for over twenty oocytes reached a plateau at 1 mM, with an estimated EC50 of 28.0 + 1.1 Mm and a Hill coefficient of 1.8+0.2. At concentrations of 10 Mm and 30 MM, GABA elicited currents 9.1+0.8% (n=21) and 55+1.3% (n = 20) of the maximum peak response respectively.
Benzodiazepines and f3-carbolines Flunitrazepam (0.1-100 Mm) had no effect on the amplitude of 10 MM GABA-induced currents (100 + 3% control, n = 6 at 100 pM) (Figure la) . Similarly, the amplitude of responses to 10 gM GABA were unaltered by 4'-chlorodiazepam (Ro5-4864) at concentrations between 1 Mm and 50 gM, but, 100 gM 4'-chlorodiazepam enhanced the response to 10 gM GABA to 180+13% control (n = 8, Figure Ib) . However, the peak amplitude of the maximum response, elicited by 1 mM GABA, was unaffected by 100 gM 4'-chlorodiazepam (99 + 1% control, n = 4).
At concentrations between 1 gM and 100 gM, the fl-carbo- 
Barbiturates
When applied alone in the perfusate at 50 gM to 1 mM, neither sodium phenobarbitone or sodium pentobarbitone altered the current required to clamp the oocyte membrane at -60 mV.
However, at concentrations greater than 10 gM the sodium salts of these barbiturates potentiated the response of RDL homo-oligomers to 10 gM GABA, in a dose-dependent manner. At 50 gM, sodium pentobarbitone enhanced the amplitude of currents induced by 10 gM GABA to 126+6% control (n = 7), and in the presence of 100 ,M and 1 mM sodium pentobarbitone the amplitudes of this GABA response were respectively 175+14% (n = 6) and 456+ 32% control (n = 3). Phenobarbitone appeared to be less potent. The response to 10 gM GABA and 50 MM phenobarbitone was 112+8% control (n= 3) whereas with 1 mm of the barbiturate, the amplitude was 342 + 26% control (n = 5). Phenobarbitone (1 mM) shifted the GABA dose-response curve to the left reducing the EC50
for GABA from 26.2 + 1.1 gM to 14.0+ 1.0 gM, and increasing the estimated Hill coefficient from 1.8 + 0.2 to 2.5 + 0.2 ( Figure  2 ). However, at 1 mM, neither barbitone affected the amplitude of the response to 3 mM GABA (97 + 1% control with sodium phenobarbitone, n =3; 98 + 2% control with sodium pentobarbitone, n = 3).
Pregnane steroids
When applied alone, 5a-pregnan-3a-ol-20-one (0.1 M -1 MM) had no effect on the current required to voltage clamp the oocyte at -60 mV, but at 5 FM to 10 MM this steroid reversibly enhanced submaximal GABA responses. In the presence of 10 MM 5a-pregnan-3a-ol-20-one the response to 6 gM GABA was 210 + 10% control (n = 4) ( Figure 3a ) and that to 10 gM GABA to 186+13% control (n = 4). 5a-Pregnan-3a-ol-20-one (10 MM) affected a slight shift to the left in the GABA dose-response curve reducing the EC50 for GABA to 20.7 ±1.lMm, while increasing the Hill slope to 2.3 + 0.4. The amplitude of the maximum GABA response was unchanged by 10 gM 5a-pregnan-3a-ol-20-one (104+2% control, n=4) ( Figure 3a (0, control) . Data were normalized to the maximum response seen with GABA alone. Each point on the modulated curve represents the mean of at least 4 experiments and is shown + s.e.mean, whereas the curve for GABA alone is fitted to the mean data from over 20 oocytes. The inset shows that the response to 6 jM GABA was enhanced by 10 gm Sa-pregnan-3x-ol-20-one (5a-3a-20-one) whereas (b) it was unaffected by 10 gmM 5c-pregnan-3fl-ol-20-one (5a-3fl-20-one).
The actions of pregnane steroids on RDL homo-oligomers are stereo-specific, as 5ox-pregnan-3fl-ol-20-one (10 gM) did not affect the amplitude of currents induced by 6 gM (101 + 4, n = 3) (Figure 3b) .
The chemically-related steroid anaesthetic alphaxalone (10 gM, 5a-pregnan-3a-ol-20-dione) also enhanced the response of RDL homo-oligomers to 10 gM GABA (152+16% control, n = 3). Lower concentrations of alphaxalone were without effect (data not shown).
Zinc
The co-applications of zinc (1-100 gM) had no effect on the amplitude of currents induced by 30 gM GABA (e.g. 97 + 3% control with 100 gM zinc, n = 4).
Loreclezole
Loreclezole (100 gM), an anticonvulsant allosteric enhancer of vertebrate GABAA receptors, enhanced the response to 10 gM GABA (180 + 10% control, n=8) (Figure 4a ), but did not increase the amplitude of the maximum GABA-induced current (99+1% control, n =5) (Figure 4b ). Lower concentrations of loreclezole (0.1-10 IOM) were without effect (data not shown).
6-Hexachlorocyclohexane (6-HCH) Figure 5 ). 6-HCH flattened the GABA dose-response curve and reduced the Hill slope to 1.2 + 0.1. As was the case for all the other positive allosteric modulators tested, 6-HCH did not increase the peak amplitude of the maximum response to GABA of these cells. The effects of 3-HCH were only partly reversed after a 10 min wash with saline.
Discussion
We have demonstrated that RDL homo-oligomers are sensitive to certain allosteric modulators. The activity of vertebrate GABAA and ionotropic invertebrate GABA receptors is subject to allosteric modulation and, from the data available, it is clear that there are differences in the effects of modulatory compounds on native vertebrate and invertebrate preparations (Sattelle et al., 1991; Rauh et al., 1993) . Here, it has been shown that the activity of RDL homo-oligomers is regulated by several of these modulatory compounds, suggesting a role for this subunit in bicuculline-insensitive insect GABA receptors that are subject to allosteric modulation. However, while the potency of some modulators (e.g. barbiturates, steroids) was in accord with that observed on in situ GABA receptors, this was not the case for others (e.g. benzodiazepines and f-carbolines). It is possible that the differences in the benzodiazepine pharmacology of RDL homo-oligomers and native GABA receptors, reflects roles for additional subunits in hetero-oligomeric native insect receptors.
Barbiturates, steroids and benzodiazepines
The barbiturates, phenobarbitone and pentobarbitone, potentiated the responses of RDL homo-oligomers to submaximal concentrations of GABA. Although full dosepotentiation studies were not conducted, it nevertheless appears that the order of potency of these two compounds on RDL homo-oligomers and GABAA receptors (Peters et al., 1988) is the same; namely pentobarbitone is more potent than phenobarbitone. However, these barbiturates were less potent modulators of RDL homo-oligomers than of GABAA receptors. In a variety of vertebrate preparations the greatest reduction in the EC50 for GABA (at least 7 fold) was affected by 100 gM to 300 gM pentobarbitone (Parker et potentiated by concentrations of Sa-pregnan-3a-ol-20-one and alphaxalone greater than 1 JM, whereas the activity of GABAA receptors is enhanced by nanomolar concentrations of the same compounds (Barker et al., 1986; Majewska et al., 1986; Callachan et al., 1987; Lambert et al., 1987; Peters et al., 1988) . This weak effect of steroids on RDL homo-oligomers prevented a detailed dose-response study but, for comparison, 10 JM 5a-pregnan-3x-ol-20-one potentiated the EClo GABA responses of RDL homo-oligomers and recombinant GABAA receptors consisting of 03, flI and Y2L subunits to approximately 180% control (this study) and 520% control respectively . Furthermore, alphaxalone, and 5a-pregnan-3a-ol-20-one, at the concentrations used here, induced GABAA receptor-mediated currents in the absence of GABA (Callachan et al., 1987; Lambert et al., 1987; Peters et al., 1988) , however, no such effect was observed on RDL homooligomers. Steroids exhibit a marked stereoselectivity for GABAA receptors with the 3fl-hydroxy isomers of pregnane steroids and alphaxalone (i.e. betaxalone) exhibiting a considerably lower efficacy than the 3a-hydroxy isomers Peters et al., 1988) . Similarly, 5a-pregnan-3fi-ol-20-one had no effect on RDL homo-oligomers at 10 JM. Pregnane steroids, including those tested here, are considerably less potent, displacers of [35S]-TBPS from Musca domestica membranes than they are from rat brain membranes (Rauh et al., 1993) , although they exhibit the same stereospecificity observed in electrophysiological experiments. Thus, RDL homooligomers closely mimic the barbiturate responses of certain in situ insect GABA receptors, and the small, stereospecific, enhancement seen with pregnane steroids appears to reflect the low affinity observed for native insect GABA receptors in radio-ligand binding studies.
Insect benzodiazepine binding sites are pharmacologically distinct from those of vertebrate GABAA receptors. The radiolabelled-benzodiazepine binding profile of insect GABA receptors differs from that of GABAA receptor in that 4'-chlorodiazepam is a more potent displacer of [3H]-flunitrazepam from insect membrane preparations, than is clonazepam (Lummis & Sattelle, 1986; Sattelle et al., 1991) . Although 4'-chlorodiazepam is a non-competitive antagonist of GABAA receptors, and appears to act at a site distinct from that of other benzodiazepine agonists or inverse agonists (Simmonds, 1985; Puia et al., 1990b) , it potently enhances the agonist response of certain insect GABA receptors (von Keyseringk & Willis, 1992; Aydar et al., 1995) . The differences in the benzodiazepine pharmacology of insect and vertebrate GABA receptors extends to the actions of /-carboline inverseagonists, which non-competitively antagonize GABA responses. Thus, while the GABA response of cockroach Df neurones are inhibited by some /-carbolines (e.g. 3-HMC) others which antagonize GABAA receptors, are inactive on the cockroach (e.g. DMCM (methyl 6,7-dimethoxy-4-ethyl-/3-carboline-3-carboxylate)) (Braestrup et al., 1982; Bai, 1994) .
The present study has shown that the potency of benzodiazepines on RDL homo-oligomers is reduced relative to that of native insect GABA receptors. At concentrations in the range 10 nM-10 kM, 4'-chlorodiazepam potentiates the GABA response of locust neurones (von Keyserlingk & Willis, 1992) and Periplaneta americana Df neurones (Y. Higashino & D. B. Sattelle, unpublished data). Peak enhancement of the GABA response of the cockroach neurones was observed with 300 nM 4'-chlorodiazepam with higher concentrations being less active. Potentiation of the GABA response of RDL homo-oligomers was observed with 100 gM 4'-chlorodiazepam, but as concentrations as high as 50 gM were ineffective, this represents an increase of over 1000 fold in the threshold for 4'-chlorodiazepam enhancement relative to the Df neurone.
Flunitrazepam, which was without effect on RDL homooligomers, markedly potentiated the GABA responses of cockroach Df neurones (Sattelle et al., 1988) and some cultured locust neurones Taylor et al., 1993) .
Flunitrazepam (1 gM) shifted the GABA dose-response curve of cockroach and locust neurones to the left, and in contrast to its effects on GABAA receptors, enhanced the maximum GABA response. However, it appears that a mixed population of GABA-benzodiazepine receptors may exist in insects, as flunitrazepam-insensitive cockroach (Aydar et al., 1995) and locust (Taylor et al., 1993) GABA receptors have been observed. Some of these GABA receptors were, however, potentiated by 4'-chlorodiazepam (Aydar et al., 1995) . RDL homo-oligomers could therefore contribute to flunitrazepam-insensitive, 4'-chlorodiazepamsensitive GABA receptors in situ. Alternatively, the lack of activity of flunitrazepam may reflect its lower affinity (than 4'-chlorodiazepam) in ligand binding studies (Lummis & Sattelle, 1986) , and it is possible that, at concentrations higher than 100 gM flunitrazepam will potentiate the activity of RDL homo-oligomers.
The actions /3-carbolines also distinguish RDL homo-oligomers from native insect GABA receptors. The GABA response of the cockroach Df motoneurone was partially blocked by 3-HMC (Bai, 1994) Puia et al., 1990a; Sigel et al., 1990; Lan et al., 1991; Puia et al., 1993) . In contrast, the co-expression of specific subunits is a prerequisite for pharmacological actions of benzodiazepines, /3-carbolines and zinc typical of subtypes of native GABAA receptors (Pritchett et al., 1989; Sigel et al., 1990; Draguhn et al., 1990; Saxena & MacDonald, 1994 (Henderson et al., 1993; Harvey et al., 1994) . A similar situation occurs with vertebrate glycine receptors, the a subunits of which form functional homo-oligomers, whereas the / subunits do not. However, the co-expression of a and /3 subunits is required for a picrotoxin pharmacology typical of some native receptors (Pribilla et al., 1992) . Given that there are both functional and sequence (Darlison, 1992; Ortells & Lunt, 1995) similarities between RDL and glycine receptor a subunits, it may be that the co-expression of RDL with LCCH3, GRD, or as yet unknown subunits will result in the formation of GABA receptors with the benzodiazepine pharmacology seen in native insect preparations.
Zinc
In vertebrates, zinc antagonizes some GABAA receptor subtypes, as well as the p subunit homo-oligomers and metabotropic GABAA receptors (Xie & Smart, 1991; Wang et al., 1994) . Expressed vertebrate a, /3, and a, /, and 6 hetero-oligomers are blocked by zinc, whereas the co-expression of a, P, and y subunits yields receptors which are insensitive to this divalent cation (Draguhn et al., 1990; Saxena & MacDonald, 1994 ). Zinc (1-100 gM) had no effect on 30 gM GABA-induced currents of RDL homo-oligomers, nor on GABA receptors of the cockroach Df neurone (Bai, 1994 (Smart & Constanti, 1982 (Olsen et al., 1989) . Although y-HCH, like picrotoxinin, is a competitive inhibitor of [3H]-EBOB binding to the house fly head membranes (Deng et al., 1993) , it should be noted that steroids, sedative and convulsant barbiturates also inhibit [35S]-TBPS binding to GABAA receptors (Ticku et al., 1985; Siegart, 1992; Haefely, 1994) , but are thought to bind at sites distinct from that for TBPS and picrotoxinin. Whether interaction with the picrotoxinin site also underlies the enhancement observed with 3-HCH remains to be determined.
Actions of loreclezole
The degree of enhancement of RDL homo-oligomers effected by loreclezole is similar to that seen on heterologously expressed GABAA receptors containing the PI subunit . Loreclezole (100 gM) enhanced the responses, to ECO GABA, or RDL homo-oligomers and mammalian receptors containing the PI subunit by approximately 80%. The efficacy of loreclezole on recombinant GABAA receptors is greatly increased in receptors expressing human f2 or P3 subunits, relative to those containing the PI subunit, by the presence of an asparagine residue at position 289, near the presumed extracellular mouth of the ion-channel . Serine and a methionine residues are found at the homologous location on PI and RDL subunits respectively.
Thus, RDL homo-oligomers form a loreclezole site similar to that seen in recombinant human receptors expressing the PI subunit. However, loreclezole has no effect on the amplitude of the maximum GABA response of RDL, although it reduced the peak response of recombinant GABAA receptors expressing both the PI and 2 subunit Wafford et al., 1994) . Presumably, the differences in the effect of 6-HCH and loreclezole on the maximum response of vertebrate GA-BAA and homo-oligomeric RDL receptors reflect differences in the interactions between the binding sites for these compounds and the determinants of ion-channel function.
Comparison of RDL homo-oligomers in two expression systems
When RDL was stably expressed in a Drosophila S2 cell line, no potentiation was observed with flunitrazepam or 4'-chlorodiazepam (0.1-1 ,IM), whereas 100 gM 4'-chlorodiazepam, effected a similar enhancement of the response to ECIo GABA as observed in Xenopus oocytes (Millar et al., 1994; S.D. Buckingham, unpublished data) . Pentobarbitone and 5a-pregnan-3a-ol-20-one exhibited a similar potency on RDL homo-oligomers in both systems, and enhanced submaximal GABA responses, while 1OMM 5a-pregnan-3fi-ol-20-one had no effect on RDL homo-oligomers in S2 cells (Millar et al., 1994; S.D. Buckingham, unpublished data) .
Comparison of allosteric modulation of two putative Rdl splice variants
The Rdl gene can undergo extensive alternate splicing, yielding four possible subunit isoforms (ffrench-Constant & Rocheleau, 1994) of which two have been cloned; RDL (ffrench-Constant et al., 1991) and DRC 17-1-2 (Chen et al., 1994) . The predicted amino acid sequence of these two subunits differs by only 17 amino acids, principally in a region of the N-terminal which influences the agonist binding site of other members of the GABAA and nicotinic acetylcholine receptor superfamily. Both subunits form GABA-gated, bicuculline-insensitive homo-oligomers when expressed in Xenopus oocytes and there appears to be little or no difference in the potentiation by pentobarbitone or 5a-pregnan-3a-ol-20-one, or 5-HCH of response of either homo-oligomer to approximately ECIo GABA (this study; Belelli et al., 1994; Chen et al., 1994) . Similarly, both receptors were insensitive to flunitrazepam (3 gM) and to 100 MM zinc. Unlike mammalian GABAA receptors, neither homooligomer responded to high concentrations of 5a-pregnan-3a-ol-20-one or pentobarbitone with picrotoxin-sensitive currents in the absence of GABA. Thus, it appears that the differences in the amino acid structure of these two subunits, do not underlie major differences in modulator pharmacology of GA-BAA receptors and Drosophila homo-oligomers.
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